tiprankstipranks
Advertisement
Advertisement

TCRT Stock Latest News

Alaunos Highlights New Preclinical Data for Obesity Therapy
Company AnnouncementsAlaunos Highlights New Preclinical Data for Obesity Therapy
4d ago
8K
TCRT
Alaunos Therapeutics reports updated preclinical data from ALN1003 mouse studies
PremiumThe Fly
Alaunos Therapeutics reports updated preclinical data from ALN1003 mouse studies
4d ago
TCRT
Valion Bio names Melinda Lackey as General Counsel
PremiumThe Fly
Valion Bio names Melinda Lackey as General Counsel
18d ago
TCRT
VBIO
Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk
PremiumCompany Announcements
Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk
1M ago
8K
TCRT
Alaunos Reports Positive Preclinical Data for Obesity Candidate
PremiumCompany Announcements
Alaunos Reports Positive Preclinical Data for Obesity Candidate
3M ago
8K
TCRT
Alaunos Therapeutics reports ‘positive’ proof-of-concept data for ALN1003
PremiumThe FlyAlaunos Therapeutics reports ‘positive’ proof-of-concept data for ALN1003
3M ago
TCRT
Alaunos Updates Governance, Ends Cantor Advisory Agreement
Premium
Company Announcements
Alaunos Updates Governance, Ends Cantor Advisory Agreement
4M ago
8K
TCRT
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
Premium
Company Announcements
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
5M ago
8K
TCRT
Alaunos Therapeutics files to sell 327,740 shares of common for holders
PremiumThe Fly
Alaunos Therapeutics files to sell 327,740 shares of common for holders
7M ago
TCRT
Alaunos Therapeutics files $50M mixed securities shelf
PremiumThe Fly
Alaunos Therapeutics files $50M mixed securities shelf
9M ago
TCRT
Alaunos Therapeutics Regains Nasdaq Compliance
PremiumCompany Announcements
Alaunos Therapeutics Regains Nasdaq Compliance
9M ago
8K
TCRT
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
PremiumCompany Announcements
Alaunos Therapeutics’ Innovative Glioblastoma Study Completes: Market Implications
9M ago
TCRT
Alaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
PremiumCompany AnnouncementsAlaunos Therapeutics’ Pediatric Brain Tumor Study Update: Implications and Insights
9M ago
TCRT
Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
Premium
Company Announcements
Alaunos Therapeutics’ TCR-T Cell Study: Long-Term Impact on Cancer Treatment
10M ago
TCRT
Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors
Premium
Company Announcements
Alaunos Therapeutics’ TCR-T Study Update: Implications for Investors
10M ago
TCRT
Alaunos Therapeutics Announces Departure of Melinda Lackey
PremiumCompany Announcements
Alaunos Therapeutics Announces Departure of Melinda Lackey
10M ago
8K
TCRT
Alaunos Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
Alaunos Therapeutics Holds Annual Stockholders Meeting
11M ago
8K
TCRT
Alaunos Therapeutics Appoints Holger Weis as New CEO
PremiumCompany Announcements
Alaunos Therapeutics Appoints Holger Weis as New CEO
11M ago
8K
TCRT
Alaunos Therapeutics Raises $850,000 in Private Offering
PremiumCompany Announcements
Alaunos Therapeutics Raises $850,000 in Private Offering
11M ago
8K
TCRT
Alaunos Therapeutics Closes Registered Direct Offering
PremiumCompany AnnouncementsAlaunos Therapeutics Closes Registered Direct Offering
11M ago
8K
TCRT
Alaunos prices 610,399 shares at $3.36 in registered direct offering
Premium
The Fly
Alaunos prices 610,399 shares at $3.36 in registered direct offering
11M ago
TCRT
Alaunos Therapeutics Amends Warrant Agreement with Mast Hill
Premium
Company Announcements
Alaunos Therapeutics Amends Warrant Agreement with Mast Hill
12M ago
8K
TCRT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >